Clinical Trials Browser

Breast Neoplasms

NCT06704659 2026-03-09

RAY-no-BAN

Phase NA Recruiting

60 enrolled

Breast

Breast Neoplasms, Recurrence

NCT04075305 2026-03-05

MOMENTUM

Recruiting

8,000 enrolled

BreastCNSGastrointestinalGenitourinaryHead & NeckThoracic

Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Genital Neoplasms, Female, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Radiation Injuries, Rectal Neoplasms

Clinical Trials

BREAST

RAY-no-BAN

MOMENTUM

A Study of Surgery and Radiotherapy in People With Breast Cancer

A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer

OLIGAMI

Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast

Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery

Preoperative Irradiation for Stage I Breast Cancer

FAST NOVEMBER

Outcomes and Cosmesis With Whole Breast Irradiation and Boost

Clinical Study of Breast Conserving Surgery Combined With Intraoperative Radiotherapy for Early Breast Cancer

Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer

Triple Negative Breast Cancer and Celecoxib. Pilot Study

PRATO

Clinical Efficacy and Safety Assessment of Breast-Conserving Surgery for Central Breast Cancer: A Prospective Randomized Controlled Trial

SAHARA-01

A Prospective, Multicenter, Observational Cohort Study Assessing the Efficacy and Safety of Radiotherapy-sensitized Immunotherapy in Advanced Breast Cancer

Phase II Clinical Trial of PD-L1 in Combination with Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy with or Without Radiotherapy for Advanced Triple-negative Breast Cancer.

LARA

Preoperative Radiotherapy and Systemic Therapy Following Surgery in 'de Novo' Metastatic Breast Cancer

Radiotherapy for Extracranial Oligometastatic Breast Cancer

A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast